Mutational and immunogenetic landscape of HCV‐associated B‐cell lymphoproliferative disorders
Open Access
- 23 March 2021
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 96 (6) , E210-E214
Abstract
No abstract availableKeywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (AIRC (under IG 2017‐ ID. 20767 project ‐ P.I. Lu)
- Fondazione IRCCS Policlinico San Matteo (Ricerca Corrente P.I. Luca Arcaini)
This publication has 6 references indexed in Scilit:
- Targeted next‐generation sequencing reveals molecular heterogeneity in non‐chronic lymphocytic leukemia clonal B‐cell lymphocytosisHematological Oncology, 2020
- A stereotyped light chain may shape virus-specific B-cell receptors in HCV-dependent lymphoproliferative disordersGenes & Immunity, 2020
- Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infectionLeukemia, 2019
- HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic ResponseGastroenterology, 2019
- Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significanceHaematologica, 2017
- Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infectionBlood, 2016